Compare Stocks

→ Move Your Money Before May 22 (From Stansberry Research) (Ad)

Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS).

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ACHL Achilles Therapeutics	$0.76 -1.3%	$1.11	$0.74 ▼ $1.76	$30.31M	1.09	661,224 shs	382,132 shs
CHV Canada House Wellness Group		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	156,525 shs
DDXS Diadexus		$0.00	$0.01 ▼ $5.40	$53K	N/A	15,481 shs	30 shs
PREV PreveCeutical Medical		$0.00	$0.00 ▼ $0.00	N/A	N/A	N/A	694,224 shs
TNGN Tengion		$0.00	$0.00 ▼ $0.00	N/A	N/A	6,051 shs	10,000 shs

5G Stocks: The Path Forward is Profitable

Click the link below and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.

Get This Free Report

Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ACHL Achilles Therapeutics	-1.91%	-3.20%	-37.55%	-19.33%	-5.56%
CHV Canada House Wellness Group	0.00%	0.00%	0.00%	0.00%	0.00%
DDXS Diadexus	0.00%	0.00%	0.00%	0.00%	0.00%
PREV PreveCeutical Medical	0.00%	0.00%	0.00%	0.00%	0.00%

These AI trades triggered this morning (545% return) (Ad)

If you think a market crash is possible in 2024, I don't know why you're not using this yet.

Click Here To Get Your Free Copy

MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ACHL Achilles Therapeutics	2.9098 of 5 stars	3.0	5.0	0.0	0.0	3.1	0.8	1.3
CHV Canada House Wellness Group	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Analyst Ratings

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
ACHL Achilles Therapeutics	2.00	Hold	$4.00	426.32% Upside
CHV Canada House Wellness Group	N/A	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A

Current Analyst Ratings

Latest ACHL, CHV, DDXS, PREV, and TNGN Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target	Details
4/5/2024	ACHL Achilles Therapeutics	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$11.00 ➝ $6.00
4/5/2024	ACHL Achilles Therapeutics	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Neutral	$8.00 ➝ $2.00

(Data available from 4/26/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ACHL Achilles Therapeutics	N/A	N/A	N/A	N/A	$3.49 per share	N/A
CHV Canada House Wellness Group	N/A	N/A	N/A	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A	N/A

Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ACHL Achilles Therapeutics	-$69.67M	-$1.74	N/A	N/A	N/A	N/A	-42.55%	-37.54%	5/8/2024 (Estimated)
CHV Canada House Wellness Group	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Latest ACHL, CHV, DDXS, PREV, and TNGN Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue	Details
4/4/2024	Q4 2023	ACHL Achilles Therapeutics	N/A	-$0.46	-$0.46	-$0.46	N/A	N/A

Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ACHL Achilles Therapeutics	N/A	N/A	N/A	N/A	N/A
CHV Canada House Wellness Group	N/A	N/A	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A	N/A	N/A

Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ACHL Achilles Therapeutics	N/A	8.57	8.57
CHV Canada House Wellness Group	N/A	N/A	N/A
DDXS Diadexus	N/A	N/A	N/A
PREV PreveCeutical Medical	N/A	N/A	N/A
TNGN Tengion	N/A	N/A	N/A

Ownership

Institutional Ownership

Company	Institutional Ownership
ACHL Achilles Therapeutics	56.38%
CHV Canada House Wellness Group	N/A
DDXS Diadexus	N/A
PREV PreveCeutical Medical	N/A
TNGN Tengion	N/A

Insider Ownership

Company	Insider Ownership
ACHL Achilles Therapeutics	5.38%
CHV Canada House Wellness Group	N/A
DDXS Diadexus	N/A
PREV PreveCeutical Medical	N/A
TNGN Tengion	N/A

Miscellaneous

Company	Employees	Shares Outstanding	Free Float	Optionable
ACHL Achilles Therapeutics	204	39.88 million	37.73 million	Not Optionable
CHV Canada House Wellness Group	N/A	N/A	N/A	Not Optionable
DDXS Diadexus	N/A	4.10 million	N/A	Not Optionable
PREV PreveCeutical Medical	N/A	N/A	N/A	Not Optionable
TNGN Tengion	147,000	N/A	N/A	Not Optionable

ACHL, CHV, DDXS, PREV, and TNGN Headlines

No headlines for this company have been tracked by MarketBeat.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

3 Value Stocks Too Small For Buffett’s Portfolio
March 28, 2024 12:16 PM
View 3 Value Stocks Too Small For Buffett’s Portfolio
Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
April 26, 2024 3:21 AM
View Stock market today: Alphabet and Microsoft help Wall Street clinch its best week in nearly 6 months
3 Stocks Leading the U.S. Agriculture Comeback
April 26, 2024 10:10 AM
View 3 Stocks Leading the U.S. Agriculture Comeback
Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
April 2, 2024 7:17 AM
View Green Gold Rush: Here's What's Driving Cannabis Stocks Higher
Bargain Hunting: 3 Stocks With RSIs That Scream Oversold
April 19, 2024 8:59 AM
View Bargain Hunting: 3 Stocks With RSIs That Scream Oversold

All Headlines

Company Descriptions

Achilles Therapeutics

NASDAQ:ACHL

Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in Phase I/IIa clinical trial for use in the treatment of metastatic or recurrent melanoma. The company was formerly known as Achilles TX Limited and changed its name to Achilles Therapeutics Plc in February 2021. Achilles Therapeutics Plc was founded in 2016 and is headquartered in London, the United Kingdom.

Canada House Wellness Group

CNSX:CHV

Canada House Cannabis Group Inc., through its subsidiaries, provides medical grade cannabis products in Canada. The company offers cannabinoid therapy products and services to patients, as well as owns and operates medicinal cannabis clinics. It also provides a cloud-based software that links physicians, providers, and patients to data that supports treatment with medical cannabis. The company serves its products under the Abba Medix, ICM Air, ICM Fogo, H-Series, Fleurs de chez nous, and Vandoos brand names. Canada House Cannabis Group Inc. is headquartered in Pickering, Canada.

Diadexus

OTCMKTS:DDXS

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

PreveCeutical Medical

CNSX:PREV

PreveCeutical Medical Inc., a health sciences company, engages in the development of options for preventive and curative therapies utilizing organic and nature identical products. Its pipeline products include Cannabinoid Sol-Gel Delivery, a cannabinoid-based nose-to-brain delivery system that provides relief from various indications, including pain, inflammation, seizures, and neurological disorders; BSV Peptide Program for targeting cancer progression; Non-Addictive Analgesic for pain management; and Dual Gene Therapy for type 2 diabetes and obesity. The company also develops a range of medicinal cannabis-based products. PreveCeutical Medical Inc. is headquartered in Vancouver, Canada.

Tengion

OTCMKTS:TNGN

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial